Maynard Um
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Artivion (AORT)
-
-
-
-
-
-
-
Needham stays Buy on Artivion Inc. (AORT) amid NEXUS FDA approval
-
-
-
-
-
-
-
Artivion presents clinical trial data at thoracic surgery meeting
-
-
-
-
-
-
-
Artivion agrees to purchase two Austin buildings for $20.5 million
-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Raised to $41 at Canaccord Genuity
-
-
-
-
-
-
-
Canaccord Genuity Starts Artivion Inc. (AORT) at Buy
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Artivion Inc. (AORT)
-
443,892 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

